In ka badan 142 milyan oo qiyaasood oo tallaalka COVID-19 ah ayaa laga bixiyay guud ahaan Shiinaha

Guddiga Caafimaadka Qaranka ee Shiinaha ayaa Axaddii sheegay in Shiinaha uu maamulay 102.4 milyan oo qiyaasood oo tallaalka COVID-19 ah laga bilaabo Maarso 27.

 

Sahayda caalamiga ah ee laba tallaal oo COVID-19 ah oo ay sameeyeen shirkadaha hoos yimaada Sinopharm ee Shiinaha ayaa dhaaftay 100 milyan, sida ay ku dhawaaqday shirkad hoos timaada Shiinaha Jimcihii. Konton waddan iyo gobollo ayaa ansixiyay tallaallada Sinopharm si loogu isticmaalo ganacsi ama xaalad degdeg ah, in ka badan 80 milyan oo qiyaasood oo labada tallaal ah ayaa la siiyay dad ka kala yimid in ka badan 190 waddan.

 

Shiinaha ayaa kor u qaadayay qorshaheeda tallaalka si loo dhiso gaashaan difaac oo ballaaran, ayuu yiri Wu Liangyou, oo ah agaasime ku xigeenka xafiiska xakamaynta cudurrada ee NHC. Qorshuhu wuxuu diiradda saarayaa kooxaha muhiimka ah, oo ay ku jiraan dadka ku nool magaalooyinka waaweyn ama kuwa dhexdhexaadka ah, magaalooyinka dekedaha ama meelaha xuduudaha, shaqaalaha shirkadaha ee dawladdu leedahay, ardayda kulliyadaha iyo macallimiinta, iyo shaqaalaha dukaamada waaweyn. Dadka da'doodu ka weyn tahay 60 sano ama qaba cudurrada daba-dheeraada ayaa sidoo kale heli kara tallaalka si looga ilaaliyo fayraska.

 

Sida laga soo xigtay Wu, 6.12 milyan oo qiyaasood oo tallaal ah ayaa la bixiyay Jimcihii.

 

Qiyaasta labaad waa in la qaataa saddex ilaa siddeed toddobaad ka dib tallaalka koowaad, sida uu ku taliyay Wang Huaqing, oo ah khabiirka ugu sareeya qorshaha tallaalka ee Xarunta Xakamaynta iyo Kahortagga Cudurrada ee Shiinaha, shir jaraa'id oo Axaddii dhacay.

 

Dadka waxaa lagula talinayaa inay qaataan laba qiyaasood oo tallaal isku mid ah, Wang ayaa yiri, isagoo intaa ku daray in qof kasta oo u qalma tallaalka uu qaadan doono tallaallada sida ugu dhakhsaha badan si loo dhiso difaaca xoolaha.

 

Labada tallaal ee Sinopharm ayaa la xaqiijiyay inay waxtar u leeyihiin in ka badan 10 nooc oo laga helo UK, Koonfur Afrika iyo meelo kale, ayuu yiri Zhang Yuntao, madaxweyne ku xigeenka China National Biotec Group, oo xiriir la leh Sinopharm.

 

Zhang ayaa sheegay in baaritaanno dheeraad ah ay socdaan oo ku saabsan noocyada kala duwan ee laga helo Brazil iyo Zimbabwe. Xogta cilmi-baarista caafimaad ee ku saabsan carruurta da'doodu u dhaxayso 3 ilaa 17 sano ayaa la filayaa, taasoo soo jeedinaysa in kooxda lagu dari karo qorshaha tallaalka mustaqbalka dhow, Zhang ayaa raaciyay.